Please enable JavaScript to continue using this application.

Compare $CAMP vs $MGNX | Chartloom

Compare

$CAMP vs $MGNX

CAMP4 Therapeutics Corp · MacroGenics Inc

CAMP

CAMP4 Therapeutics Corp

MGNX

MacroGenics Inc

Compare $CAMP vs $MGNX

Comparing CAMP4 Therapeutics Corp and MacroGenics Inc

CAMPCAMP4 Therapeutics Corp

MGNXMacroGenics Inc

CAMPCAMP4 Therapeutics Corp

Market cap

$196M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.59x

Rev growth (TTM)

40.3%

YTD performance

-37.2%

52W performance

6.5%

FCF yield

-14.7%

MGNXMacroGenics Inc

Market cap

$238M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.39x

Rev growth (TTM)

1.3%

YTD performance

132.3%

52W performance

110.1%

FCF yield

-27.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CAMP

MGNX

Detailed metrics comparison

CAMP

CAMP4 Therapeutics Corp

MGNX

MacroGenics Inc

Market Cap

CAMP$196M

MGNX$238M

Enterprise Value

CAMP$109M

MGNX$302M

Price

CAMP$3.77

MGNX$3.74

P/E Ratio

CAMPN/A

MGNXN/A

P/S Ratio

CAMP46.44x

MGNX1.42x

EV/Sales

CAMP25.94x

MGNX1.80x

EV/EBITDA

CAMP0.00x

MGNX5.31x

P/B Ratio

CAMP8.12x

MGNX5.32x

P/FCF Ratio

CAMPN/A

MGNXN/A

EV/FCF

CAMP-3.81x

MGNX-4.61x

PEG Ratio

CAMPN/A

MGNXN/A

Forward P/E (NTM)

CAMPN/A

MGNXN/A

Forward P/S (NTM)

CAMP19.59x

MGNX2.39x

Revenue (TTM)

CAMP$4M

MGNX$168M

Revenue Growth (YoY)

CAMP40.3%

MGNX1.3%

Forward Rev Growth

CAMP-10.8%

MGNX-12.8%

Gross Margin (TTM)

CAMP35.8%

MGNX61.8%

Operating Margin (TTM)

CAMP0.0%

MGNX0.0%

EBITDA Margin (TTM)

CAMP-1199.3%

MGNX-20.8%

Net Margin (TTM)

CAMP-2543.7%

MGNX-8.7%

FCF Margin (TTM)

CAMP-681.2%

MGNX-39.1%

Net Income (TTM)

CAMP$-107M

MGNX$-15M

FCF (TTM)

CAMP$-29M

MGNX$-66M

EPS (TTM)

CAMP-$1.85

MGNX-$0.23

ROE (TTM)

CAMP-19474.0%

MGNX-3127.0%

ROA (TTM)

CAMP-10642.0%

MGNX-535.0%

ROIC (TTM)

CAMP-19457.0%

MGNX-1017.0%

Cash

CAMP$86M

MGNX$114M

Debt

CAMP$0

MGNX$178M

Net Cash/Debt

CAMP$86M

MGNX$-64M

Current Ratio (TTM)

CAMP4.70x

MGNX2.96x

Quick Ratio (TTM)

CAMP4.69x

MGNX2.92x

Debt/Equity (TTM)

CAMP0.00x

MGNX4.16x

Debt/Assets (TTM)

CAMP0.0%

MGNX0.0%

Interest Coverage (TTM)

CAMPN/A

MGNXN/A

Net Debt/EBITDA (TTM)

CAMP0.00x

MGNX0.00x

Beta

CAMP-24.51

MGNX1.25

52W Performance

CAMP6.5%

MGNX110.1%

YTD Performance

CAMP-37.2%

MGNX132.3%

% from 52W High

CAMP-51.4%

MGNX-26.4%

% from 52W Low

CAMP31.8%

MGNX189.9%

Asset Turnover (TTM)

CAMP0.79x

MGNX0.61x

FCF Yield (TTM)

CAMP-14.7%

MGNX-27.6%

Earnings Yield (TTM)

CAMP-54.8%

MGNX-6.1%

Dividend Yield (TTM)

CAMPN/A

MGNXN/A

Rule of 40

CAMP-640.9

MGNX-37.8

EV/GP/RG

CAMP0.53

MGNXN/A

Ticker research

View CAMP research View MGNX research

Metric	CAMP CAMP4 Therapeutics Corp	MGNX MacroGenics Inc
Market & Valuation
Market Cap	$196M	$238M
Enterprise Value	$109M	$302M
Price	$3.77	$3.74
P/E Ratio	N/A	N/A
P/S Ratio	46.44x	1.42x
EV/Sales	25.94x	1.80x
EV/EBITDA	0.00x	5.31x
P/B Ratio	8.12x	5.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.81x	-4.61x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.59x	2.39x
Revenue & Growth
Revenue (TTM)	$4M	$168M
Revenue Growth (YoY)	40.3%	1.3%
Forward Rev Growth	-10.8%	-12.8%
Profitability
Gross Margin (TTM)	35.8%	61.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1199.3%	-20.8%
Net Margin (TTM)	-2543.7%	-8.7%
FCF Margin (TTM)	-681.2%	-39.1%
Net Income (TTM)	$-107M	$-15M
FCF (TTM)	$-29M	$-66M
EPS (TTM)	-$1.85	-$0.23
ROE (TTM)	-19474.0%	-3127.0%
ROA (TTM)	-10642.0%	-535.0%
ROIC (TTM)	-19457.0%	-1017.0%
Financial Health
Cash	$86M	$114M
Debt	$0	$178M
Net Cash/Debt	$86M	$-64M
Current Ratio (TTM)	4.70x	2.96x
Quick Ratio (TTM)	4.69x	2.92x
Debt/Equity (TTM)	0.00x	4.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-24.51	1.25
52W Performance	6.5%	110.1%
YTD Performance	-37.2%	132.3%
% from 52W High	-51.4%	-26.4%
% from 52W Low	31.8%	189.9%
Efficiency & Yields
Asset Turnover (TTM)	0.79x	0.61x
FCF Yield (TTM)	-14.7%	-27.6%
Earnings Yield (TTM)	-54.8%	-6.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-640.9	-37.8
EV/GP/RG	0.53	N/A
Ticker research	View CAMP research	View MGNX research

Valuation

P/S Ratio

MGNX

1.42x

CAMP

46.44x

EV/FCF

MGNX

-4.61x

CAMP

-3.81x

Growth & revenue

Revenue Growth TTM

CAMP

40.3%

MGNX

1.3%

Forward Revenue Growth

CAMP

-10.8%

MGNX

-12.8%

Profitability & performance

Gross Margin

MGNX

61.8%

CAMP

35.8%

ROE

MGNX

-3127.0%

CAMP

-19474.0%

FCF Yield %

CAMP

-14.7%

MGNX

-27.6%

52-Week Performance

MGNX

110.1%

CAMP

6.5%

Detailed metrics comparison

CAMP

CAMP4 Therapeutics Corp

MGNX

MacroGenics Inc

Market Cap

CAMP$196M

MGNX$238M

Enterprise Value

CAMP$109M

MGNX$302M

Price

CAMP$3.77

MGNX$3.74

P/E Ratio

CAMPN/A

MGNXN/A

P/S Ratio

CAMP46.44x

MGNX1.42x

EV/Sales

CAMP25.94x

MGNX1.80x

EV/EBITDA

CAMP0.00x

MGNX5.31x

P/B Ratio

CAMP8.12x

MGNX5.32x

P/FCF Ratio

CAMPN/A

MGNXN/A

EV/FCF

CAMP-3.81x

MGNX-4.61x

PEG Ratio

CAMPN/A

MGNXN/A

Forward P/E (NTM)

CAMPN/A

MGNXN/A

Forward P/S (NTM)

CAMP19.59x

MGNX2.39x

Revenue (TTM)

CAMP$4M

MGNX$168M

Revenue Growth (YoY)

CAMP40.3%

MGNX1.3%

Forward Rev Growth

CAMP-10.8%

MGNX-12.8%

Gross Margin (TTM)

CAMP35.8%

MGNX61.8%

Operating Margin (TTM)

CAMP0.0%

MGNX0.0%

EBITDA Margin (TTM)

CAMP-1199.3%

MGNX-20.8%

Net Margin (TTM)

CAMP-2543.7%

MGNX-8.7%

FCF Margin (TTM)

CAMP-681.2%

MGNX-39.1%

Net Income (TTM)

CAMP$-107M

MGNX$-15M

FCF (TTM)

CAMP$-29M

MGNX$-66M

EPS (TTM)

CAMP-$1.85

MGNX-$0.23

ROE (TTM)

CAMP-19474.0%

MGNX-3127.0%

ROA (TTM)

CAMP-10642.0%

MGNX-535.0%

ROIC (TTM)

CAMP-19457.0%

MGNX-1017.0%

Cash

CAMP$86M

MGNX$114M

Debt

CAMP$0

MGNX$178M

Net Cash/Debt

CAMP$86M

MGNX$-64M

Current Ratio (TTM)

CAMP4.70x

MGNX2.96x

Quick Ratio (TTM)

CAMP4.69x

MGNX2.92x

Debt/Equity (TTM)

CAMP0.00x

MGNX4.16x

Debt/Assets (TTM)

CAMP0.0%

MGNX0.0%

Interest Coverage (TTM)

CAMPN/A

MGNXN/A

Net Debt/EBITDA (TTM)

CAMP0.00x

MGNX0.00x

Beta

CAMP-24.51

MGNX1.25

52W Performance

CAMP6.5%

MGNX110.1%

YTD Performance

CAMP-37.2%

MGNX132.3%

% from 52W High

CAMP-51.4%

MGNX-26.4%

% from 52W Low

CAMP31.8%

MGNX189.9%

Asset Turnover (TTM)

CAMP0.79x

MGNX0.61x

FCF Yield (TTM)

CAMP-14.7%

MGNX-27.6%

Earnings Yield (TTM)

CAMP-54.8%

MGNX-6.1%

Dividend Yield (TTM)

CAMPN/A

MGNXN/A

Rule of 40

CAMP-640.9

MGNX-37.8

EV/GP/RG

CAMP0.53

MGNXN/A

Ticker research

View CAMP research View MGNX research

Metric	CAMP CAMP4 Therapeutics Corp	MGNX MacroGenics Inc
Market & Valuation
Market Cap	$196M	$238M
Enterprise Value	$109M	$302M
Price	$3.77	$3.74
P/E Ratio	N/A	N/A
P/S Ratio	46.44x	1.42x
EV/Sales	25.94x	1.80x
EV/EBITDA	0.00x	5.31x
P/B Ratio	8.12x	5.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.81x	-4.61x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.59x	2.39x
Revenue & Growth
Revenue (TTM)	$4M	$168M
Revenue Growth (YoY)	40.3%	1.3%
Forward Rev Growth	-10.8%	-12.8%
Profitability
Gross Margin (TTM)	35.8%	61.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1199.3%	-20.8%
Net Margin (TTM)	-2543.7%	-8.7%
FCF Margin (TTM)	-681.2%	-39.1%
Net Income (TTM)	$-107M	$-15M
FCF (TTM)	$-29M	$-66M
EPS (TTM)	-$1.85	-$0.23
ROE (TTM)	-19474.0%	-3127.0%
ROA (TTM)	-10642.0%	-535.0%
ROIC (TTM)	-19457.0%	-1017.0%
Financial Health
Cash	$86M	$114M
Debt	$0	$178M
Net Cash/Debt	$86M	$-64M
Current Ratio (TTM)	4.70x	2.96x
Quick Ratio (TTM)	4.69x	2.92x
Debt/Equity (TTM)	0.00x	4.16x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-24.51	1.25
52W Performance	6.5%	110.1%
YTD Performance	-37.2%	132.3%
% from 52W High	-51.4%	-26.4%
% from 52W Low	31.8%	189.9%
Efficiency & Yields
Asset Turnover (TTM)	0.79x	0.61x
FCF Yield (TTM)	-14.7%	-27.6%
Earnings Yield (TTM)	-54.8%	-6.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-640.9	-37.8
EV/GP/RG	0.53	N/A
Ticker research	View CAMP research	View MGNX research